TNF and neoplasm: Therefore, it may be possible for the autocrine TNFα produced by circulating or tumor-infiltrating myeloid cells61,62, for example, in patients treated with Smac mimetics to cooperate with the drug to trigger sublethal apoptotic signaling in noncancerous cells, which may be mutagenic and potentially could lead to oncogenic transformation.